Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Neuroendocrine Tumors 14Carcinoid Tumor 5Gastro-enteropancreatic neuroendocrine tumor 4Acromegaly 3Serotonin Syndrome 2Pituitary Neoplasms 2Pheochromocytoma 1Paraganglioma 1Neuroendocrine Tumour With Carcinoid Symptoms 1Neuroendocrine Tumors in Lung 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Growth Hormone-Secreting Pituitary Adenoma 1Gigantism 1Gastrointestinal Neoplasms 1Flushing 1Diarrhea 1Carcinoma, Hepatocellular 1Carcinoid Heart Disease 1Adenoma, Islet Cell 1

Interventions

lanreotide 1Sorafenib 1Radiofrequency Ablation 1Octreotide 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × lanreotide × Endocrine × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡